P21441 AF NFT

Multidrug resistance protein

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeie455o6a2ltufisfr6zdkeykcsrs6bhvjopjsa4bigpomwgou4vnq/metadata.json
IPFS of structure file: 
bafybeidufeq2alfgt6ssagyjuc7ilannlimaqki3zryjo2unkxjofk356e/AF-P21441-F1-model_v2.pdb
First NFT owner address (eip-55): 
0x816B516Cd446dB1CAb3b8Ed3D0e41098ba7161A6
First NFT owner address (bech32): 
genesis1s944zmx5gmd3e2em3mfapeqsnza8zcdxepfhk6
Current NFT ID #227951 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
227951
Accession (UniProt):
P21441
Name::
Multidrug resistance protein
Experimental Method:
Predicted structure
Sequence source:
LEISHMANIA TARENTOLAE

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT P21441 research and analysis (ICN3D with VR)

FASTA sequences

>sp|P21441|MDR_LEITA Multidrug resistance protein OS=Leishmania tarentolae OX=5689 GN=PGPA PE=3 SV=2 MVDNGHVTIAMADLGTVVEIAQVRCQQEAQRKFAEQLDELWGGEPAYTPTVEDQASWFQQLYYGWIGDYIYKAAAGNITEADLPPPTRSTRTYHIGRKLSRQAHADIDASRRWQGYIGCEVVYKSEAEAKGVLRWVGHLQQSDYPRSLVAGVEWRMPPRHRRLAVLGSAAALHNGVVHGERLFWPHEDNYLCSCEPVEQLYVKSKYNLIPPRPPPSPDLLRTLFKVHWYHVWAQILPKLLSDVTALMLPVLLEYFVKYLNADNATWGWGLGLALTIFLTNVIQSCSAHKYDHISIRTAALFETSSMALLFEKCFTVSRRSLQRPDMSVGRIMNMVGNDVDNIGSLNWYVMYFWSAPLQLVLCLLLLIRLVGWLRVPGMAVLFVTLPLQAVISKHVQDVSERMASVVDLRIKRTNELLSGVRIVKFMGWEPVFLARIQDARSRELRCLRDVHVANVFFMFVNDATPTLVIAVVFILYHVSGKVLKPEVVFPTIALLNTMRVSFFMIPIIISSILQCFVSAKRVTAFIECPDTHSQVQDIASIDVPDAAAIFKGASIHTYLPVKLPRCKSRLTAMQRSTLWFRRRGVPETEWYEVDSPDASASSLAVHSTTVHMGSTQTVITDSDGAAGEDEKGEVEEGDREYYQLVSKELLRNVSLTIPKGKLTMVIGSTGSGKSTLLGALMGEYSVESGELWAERSIAYVPQQAWIMNATLRGNILFFDEERAEDLQDVIRCCQLEADLAQFCGGLDTEIGEMGVNLSGGQKARVSLARAVYANRDVYLLDDPLSALDAHVGQRIVQDVILGRLRGKTRVLATHQIHLLPLADYIVVLQHGSIVFAGDFAAFSATALEETLRGELKGSKDVESCSSDVDTESATAETAPYVAKAKGLNAEQETSLAGGEDPLRSDVEAGRLMTTEEKATGKVPWSTYVAYLKSCGGLEAWGCLLATFALTECVTAASSVWLSIWSTGSLMWSADTYLYVYLFIVFLEIFGSPLRFFLCYYLIRIGSRNMHRDLLESIGVARMSFFDTTPVGRVLNRFTKDMSILDNTLNDGYLYLLEYFFSMCSTVIIMVVVQPFVLVAIVPCVYSYYKLMQVYNASNRETRRIKSIAHSPVFTLLEESLQGQRTIATYGKLHLVLQEALGRLDVVYSALYMQNVSNRWLGVRLEFLSCVVTFMVAFIGVIGKMEGASSQNIGLISLSLTMSMTLTETLNWLVRQVAMVEANMNSVERVLHYTQEVEHEHVPEMGELVAQLVRSESGRGANVTETVVIESAGAASSALHPVQAGSLVLEGVQMRYREGLPLVLRGVSFQIAPREKVGIVGRTGSGKSTLLLTFMRMVEVCGGVIHVNGREMSAYGLRDVRRHFSMIPQDPVLFDGTVRQNVDPFLEASSAEVWAALELVGLRERVASESEGIDSRVLEGGSNYSVGQRQLMCMARALLKRGSGFILMDEATANIDPALDRQIQATVMSAFSAYTVITIAHRLHTVAQYDKIIVMDHGVVAEMGSPRELVMNHQSMFHSMVESLGSRGSKDFYELLMGRRIVQPAVLSD